Your shopping cart is currently empty

SR-31747 blocks cell proliferation by inhibiting sterol isomerase. SR-31747 is a sigma ligand. It has immunosuppressive and anti-inflammatory properties.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 5 mg | $970 | 6-8 weeks | 6-8 weeks | |
| 25 mg | $1,520 | 6-8 weeks | 6-8 weeks | |
| 50 mg | $1,980 | 6-8 weeks | 6-8 weeks | |
| 100 mg | $2,500 | 6-8 weeks | 6-8 weeks | |
| 1 mL x 10 mM (in DMSO) | $1,068 | 6-8 weeks | 6-8 weeks |
| Description | SR-31747 blocks cell proliferation by inhibiting sterol isomerase. SR-31747 is a sigma ligand. It has immunosuppressive and anti-inflammatory properties. |
| In vitro | SR-31747 (10 nM) blocks the proliferation of lymphocytes at a concentration. SR-31747 arrests proliferation in yeast cells in a dose-dependent manner. SR-31747 is capable of inhibiting T-cell proliferation when added as late as 24 h after activation [2]. |
| In vivo | SR-31747 dramatically blocks lipopolysaccharide-induced production of IL-1, IL-6, and TNF-α in a dose-dependent manner (ED50: 2 mg/kg) in vivo. SR-31747 probably abrogated monokine production through an indirect mechanism that involves endogenous corticosteroids. Ablation of corticosteroids by the use of Mifepristone or adrenalectomy suppresses the effect of SR-31747. Administration of SR-31747 induces an enhancement of the corticosterone level. SR-31747 improves the survival of animals with endotoxic shock as a result of monokine inhibition [1]. |
| Molecular Weight | 396.44 |
| Formula | C23H35Cl2N |
| Cas No. | 132173-07-0 |
| Smiles | Cl.CCN(C\C=C/c1ccc(C2CCCCC2)c(Cl)c1)C1CCCCC1 |
| Relative Density. | no data available |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||
| Solubility Information | DMSO: 15.62 mg/mL (39.4 mM), Sonication is recommended. | |||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween-80+45% Saline: 1.5 mg/mL (3.78 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.